NEW YORK, April 3 - Myriad Genetics said today that it was tapped by DuPont to help the chemical giant's agbio division build a better seed.

Myriad will get $24 million over two years to apply its genomic-sequencing technology and bioinformatics experience to collect and deliver certain molecular-genetic information to the unit, Pioneer.

Financial details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.